{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T09:03:56Z","timestamp":1774343036928,"version":"3.50.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,4,6]]},"DOI":"10.7759\/cureus.57705","type":"journal-article","created":{"date-parts":[[2024,4,6]],"date-time":"2024-04-06T11:25:26Z","timestamp":1712402726000},"source":"Crossref","is-referenced-by-count":1,"title":["Guillain-Barr\u00e9 Syndrome After a SARS-CoV-2 Vaccine"],"prefix":"10.7759","author":[{"given":"Ana M","family":"Oliveira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patr\u00edcia","family":"Varela Ramos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gon\u00e7alo","family":"Dur\u00e3o-Carvalho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V\u00e2nia","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo\u00e3o","family":"Gon\u00e7alves Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/iid3.875","article-title":"COVID-19 as a trigger of Guillain-Barr\u00e9 syndrome: a review of the molecular mechanism","volume":"11","author":"Malekpour M","year":"2023","unstructured":"Malekpour M, Khanmohammadi S, Meybodi MJ, Shekouh D, Rahmanian MR, Kardeh S, Azarpira N. COVID-19 as a trigger of Guillain-Barr\u00e9 syndrome: a review of the molecular mechanism. Immun Inflamm Dis. 2023, 11:e875. 10.1002\/iid3.875","journal-title":"Immun Inflamm Dis"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.25678","article-title":"Outbreak of pneumonia of unknown etiology in Wuhan, China: the mystery and the miracle","volume":"92","author":"Lu H","year":"2020","unstructured":"Lu H, Stratton CW, Tang YW. Outbreak of pneumonia of unknown etiology in Wuhan, China: the mystery and the miracle. J Med Virol. 2020, 92:401-2. 10.1002\/jmv.25678","journal-title":"J Med Virol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.7930","article-title":"Neurological complications of coronavirus disease (COVID-19): encephalopathy, MRI brain and cerebrospinal fluid findings: case 2","volume":"12","author":"Espinosa PS","year":"2020","unstructured":"Espinosa PS, Rizvi Z, Sharma P, Hindi F, Filatov A. Neurological complications of coronavirus disease (COVID-19): encephalopathy, MRI brain and cerebrospinal fluid findings: case 2. Cureus. 2020, 12:e7930. 10.7759\/cureus.7930","journal-title":"Cureus"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.7352","article-title":"Neurological complications of coronavirus disease (COVID-19): encephalopathy","volume":"12","author":"Filatov A","year":"2020","unstructured":"Filatov A, Sharma P, Hindi F, Espinosa PS. Neurological complications of coronavirus disease (COVID-19): encephalopathy. Cureus. 2020, 12:e7352. 10.7759\/cureus.7352","journal-title":"Cureus"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/mus.27024","article-title":"COVID-19-associated Guillain-Barr\u00e9 syndrome: the early pandemic experience","volume":"62","author":"Caress JB","year":"2020","unstructured":"Caress JB, Castoro RJ, Simmons Z, Scelsa SN, Lewis RA, Ahlawat A, Narayanaswami P. COVID-19-associated Guillain-Barr\u00e9 syndrome: the early pandemic experience. Muscle Nerve. 2020, 62:485-91. 10.1002\/mus.27024","journal-title":"Muscle Nerve"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine","volume":"383","author":"Polack FP","year":"2020","unstructured":"Polack FP, Thomas SJ, Kitchin N, et al.. Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine. N Engl J Med. 2020, 383:2603-15. 10.1056\/NEJMoa2034577","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.13426","article-title":"Neurological complications of COVID-19: Guillain-Barre syndrome following Pfizer COVID-19 vaccine","volume":"13","author":"Waheed S","year":"2021","unstructured":"Waheed S, Bayas A, Hindi F, Rizvi Z, Espinosa PS. Neurological complications of COVID-19: Guillain-Barre syndrome following Pfizer COVID-19 vaccine. Cureus. 2021, 13:e13426. 10.7759\/cureus.13426","journal-title":"Cureus"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00517-1","article-title":"Guillain-Barr\u00e9 syndrome","volume":"397","author":"Shahrizaila N","year":"2021","unstructured":"Shahrizaila N, Lehmann HC, Kuwabara S. Guillain-Barr\u00e9 syndrome. Lancet. 2021, 397:1214-28. 10.1016\/S0140-6736(21)00517-1","journal-title":"Lancet"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awaa444","article-title":"COVID-19 vaccine and Guillain-Barr\u00e9 syndrome: let's not leap to associations","volume":"144","author":"Lunn MP","year":"2021","unstructured":"Lunn MP, Cornblath DR, Jacobs BC, Querol L, van Doorn PA, Hughes RA, Willison HJ. COVID-19 vaccine and Guillain-Barr\u00e9 syndrome: let's not leap to associations. Brain. 2021, 144:357-60. 10.1093\/brain\/awaa444","journal-title":"Brain"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200932040-00005","article-title":"Vaccines and Guillain-Barr\u00e9 syndrome","volume":"32","author":"Haber P","year":"2009","unstructured":"Haber P, Sejvar J, Mikaeloff Y, DeStefano F. Vaccines and Guillain-Barr\u00e9 syndrome. Drug Saf. 2009, 32:309-23. 10.2165\/00002018-200932040-00005","journal-title":"Drug Saf"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.37578","article-title":"Guillain-Barr\u00e9 syndrome induced by vaccination against COVID-19: a systematic review and meta-analysis","volume":"15","author":"Ogunjimi OB","year":"2023","unstructured":"Ogunjimi OB, Tsalamandris G, Paladini A, Varrassi G, Zis P. Guillain-Barr\u00e9 syndrome induced by vaccination against COVID-19: a systematic review and meta-analysis. Cureus. 2023, 15:e37578. 10.7759\/cureus.37578","journal-title":"Cureus"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2020.1127","article-title":"Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China","volume":"77","author":"Mao L","year":"2020","unstructured":"Mao L, Jin H, Wang M, et al.. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020, 77:683-90. 10.1001\/jamaneurol.2020.1127","journal-title":"JAMA Neurol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1078197","article-title":"Guillain-Barre syndrome following COVID-19 vaccines: a review of literature","volume":"14","author":"Yu M","year":"2023","unstructured":"Yu M, Nie S, Qiao Y, Ma Y. Guillain-Barre syndrome following COVID-19 vaccines: a review of literature. Front Immunol. 2023, 14:1078197. 10.3389\/fimmu.2023.1078197","journal-title":"Front Immunol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awac067","article-title":"COVID-19 vaccination and Guillain-Barr\u00e9 syndrome: analyses using the National Immunoglobulin Database","volume":"146","author":"Keh RY","year":"2023","unstructured":"Keh RY, Scanlon S, Datta-Nemdharry P, et al.. COVID-19 vaccination and Guillain-Barr\u00e9 syndrome: analyses using the National Immunoglobulin Database. Brain. 2023, 146:739-48. 10.1093\/brain\/awac067","journal-title":"Brain"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-021-05733-x","article-title":"Guillain-Barr\u00e9 syndrome following the first dose of Pfizer-BioNTech COVID-19 vaccine: case report and review of reported cases","volume":"43","author":"Bouattour N","year":"2022","unstructured":"Bouattour N, Hdiji O, Sakka S, et al.. Guillain-Barr\u00e9 syndrome following the first dose of Pfizer-BioNTech COVID-19 vaccine: case report and review of reported cases. Neurol Sci. 2022, 43:755-61. 10.1007\/s10072-021-05733-x","journal-title":"Neurol Sci"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/imm.13443","article-title":"New-onset autoimmune phenomena post-COVID-19 vaccination","volume":"165","author":"Chen Y","year":"2022","unstructured":"Chen Y, Xu Z, Wang P, Li XM, Shuai ZW, Ye DQ, Pan HF. New-onset autoimmune phenomena post-COVID-19 vaccination. Immunology. 2022, 165:386-401. 10.1111\/imm.13443","journal-title":"Immunology"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.53845","article-title":"Reports of Guillain-Barr\u00e9 syndrome after COVID-19 vaccination in the United States","volume":"6","author":"Abara WE","year":"2023","unstructured":"Abara WE, Gee J, Marquez P, et al.. Reports of Guillain-Barr\u00e9 syndrome after COVID-19 vaccination in the United States. JAMA Netw Open. 2023, 6:e2253845. 10.1001\/jamanetworkopen.2022.53845","journal-title":"JAMA Netw Open"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-023-01055-0","article-title":"Is there a causal nexus between COVID-19 infection, COVID-19 vaccination, and Guillain-Barr\u00e9 syndrome?","volume":"28","author":"Zheng X","year":"2023","unstructured":"Zheng X, Fang Y, Song Y, Liu S, Liu K, Zhu J, Wu X. Is there a causal nexus between COVID-19 infection, COVID-19 vaccination, and Guillain-Barr\u00e9 syndrome?. Eur J Med Res. 2023, 28:98. 10.1186\/s40001-023-01055-0","journal-title":"Eur J Med Res"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbih.2022.100578","article-title":"Guillain-Barr\u00e9 syndrome associated with COVID-19: a systematic review","volume":"28","author":"Pimentel V","year":"2023","unstructured":"Pimentel V, Luchsinger VW, Carvalho GL, et al.. Guillain-Barr\u00e9 syndrome associated with COVID-19: a systematic review. Brain Behav Immun Health. 2023, 28:100578. 10.1016\/j.bbih.2022.100578","journal-title":"Brain Behav Immun Health"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2011-301882","article-title":"Outcome and its predictors in Guillain-Barre syndrome","volume":"83","author":"Rajabally YA","year":"2012","unstructured":"Rajabally YA, Uncini A. Outcome and its predictors in Guillain-Barre syndrome. J Neurol Neurosurg Psychiatry. 2012, 83:711-8. 10.1136\/jnnp-2011-301882","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/229609-guillain-barr-syndrome-after-a-sars-cov-2-vaccine","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,6]],"date-time":"2024-04-06T11:25:29Z","timestamp":1712402729000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/229609-guillain-barr-syndrome-after-a-sars-cov-2-vaccine"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,6]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.57705","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4,6]]}}}